AIF1 Gene

Overview

Aif1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Pathway Diagram

flowchart TD
    AIF1["AIF1"]
    MICROGLIA["MICROGLIA"]
    AIF1 -->|"expressed in"| MICROGLIA
    Microglial_Activation["Microglial Activation"]
    AIF1 -->|"biomarker for"| Microglial_Activation
    Neurodegeneration["Neurodegeneration"]
    AIF1 -.->|"inhibits"| Neurodegeneration
    Inflammation["Inflammation"]
    AIF1 -.->|"inhibits"| Inflammation
    Als["Als"]
    AIF1 -.->|"inhibits"| Als
    Aging["Aging"]
    AIF1 -.->|"inhibits"| Aging
    Tumor["Tumor"]
    AIF1 -.->|"inhibits"| Tumor
    Parkinson["Parkinson"]
    AIF1 -.->|"inhibits"| Parkinson
    CKLF["CKLF"]
    CKLF -->|"contributes_to"| AIF1
    style AIF1 fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style MICROGLIA fill:#263238,stroke:#90a4ae,color:#90a4ae
    style Microglial_Activation fill:#e65100,stroke:#ff8a65,color:#ff8a65
    style Neurodegeneration fill:#4a0000,stroke:#ef5350,color:#ef5350
    style Inflammation fill:#4a0000,stroke:#ef5350,color:#ef5350
    style Als fill:#4a0000,stroke:#ef5350,color:#ef5350
    style Aging fill:#4a0000,stroke:#ef5350,color:#ef5350
    style Tumor fill:#4a0000,stroke:#ef5350,color:#ef5350
    style Parkinson fill:#4a0000,stroke:#ef5350,color:#ef5350
    style CKLF fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7

Knowledge graph relationships for AIF1 (307 total edges in KG)

Introduction

AIF1 (allograft inflammatory factor 1; IBA1) encodes a calcium-binding cytoskeletal adaptor that is strongly enriched in microglia. In neurodegenerative disease research, AIF1 is used as a core readout for microglial recruitment, morphology, and activation state around pathology such as amyloid-beta, tau, and alpha-synuclein.^{1A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage1996 · Biochem Biophys Res Commun · PMID 8521795Open reference2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference}

Molecular Function

AIF1 is an EF-hand calcium-binding protein that couples inflammatory signaling to actin remodeling. In activated microglia it supports membrane ruffling, process extension/retraction, migration toward chemotactic signals, and phagocytic cup formation.^{1A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage1996 · Biochem Biophys Res Commun · PMID 8521795Open reference3Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity2001 · J Neurochem · PMID 11675512Open reference} Because these behaviors are central to tissue surveillance and debris clearance, AIF1 expression generally rises as microglia transition from homeostatic states to injury- or disease-responsive states.^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference4The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases2017 · Immunity · DOI 10.1016/j.immuni.2017.08.008Open reference}

Key functional themes include:

• Calcium-dependent regulation of actin dynamics

• Phagocytosis and lysosomal cargo handling in response to protein aggregates

• Integration with complement system driven synapse and debris clearance

• Participation in inflammatory reprogramming alongside TREM2, APOE, and TYROBP modules^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference4The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases2017 · Immunity · DOI 10.1016/j.immuni.2017.08.008Open reference}

Role in Neurodegeneration

Alzheimer’s disease

In Alzheimer’s disease, AIF1-positive microglia accumulate around plaques and dystrophic neurites, where they can provide both protective and harmful effects depending on timing and state.^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference5Neuroinflammation in Alzheimer's disease2015 · Lancet Neurol · DOI 10.1016/S1474-4422(15Open reference} Early responses may support compaction/containment of amyloid deposits, but chronic inflammatory signaling is associated with synaptic stress and network dysfunction.^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference}0^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference}1

AIF1 staining is therefore interpreted together with disease-stage markers and signaling pathways such as NLRP3 inflammasome, NF-kB, and microglia-neuroinflammation.

Parkinson’s disease

In Parkinson’s disease, AIF1-positive microglia are increased in vulnerable regions including substantia nigra.^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference}2 Interaction with neuronal alpha-synuclein species can amplify cytokine signaling and oxidative stress programs that contribute to dopaminergic vulnerability.^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference}3^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference}4

ALS and related motor disorders

In amyotrophic lateral sclerosis, elevated AIF1 signal is commonly observed in spinal and corticospinal compartments and tracks with myeloid activation around degenerating motor units.^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference}5 Similar patterns are reported across frontotemporal and multisystem neurodegenerative syndromes with strong neuroimmune components.^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference}6^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference}7

Mechanistic Position in the Gene-Protein-Pathway Axis

AIF1 can be placed in a practical mechanistic chain:

1. Misfolded proteins or neuronal stress activate innate immune sensing.

2. Microglia switch from homeostatic states to disease-associated states.

3. AIF1 expression rises with motility and phagocytic remodeling programs.

4. Downstream outcomes diverge between protective debris handling and chronic feed-forward neuroinflammation.^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference}8^{2A unique microglia type associated with restricting development of Alzheimer's disease2017 · Cell · DOI 10.1016/j.cell.2017.05.018Open reference}9^{1A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage1996 · Biochem Biophys Res Commun · PMID 8521795Open reference}0

This framing links AIF1 to broader pathways in selective neuronal vulnerability, oxidative stress, and complement-mediated-synapse-loss.

Biomarker and Translational Relevance

AIF1 is primarily a tissue-level and imaging-adjacent marker rather than a standalone circulating diagnostic biomarker. Its translational value is strongest when integrated with multimodal readouts:

• Histopathology: microglial burden and morphology

• Transcriptomics: homeostatic-to-inflammatory state transitions

• Imaging/pathology correlation with amyloid/tau/alpha-syn pathology load

• Intervention studies targeting TREM2 therapeutics, complement signaling, or inflammasome pathways^{1A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage1996 · Biochem Biophys Res Commun · PMID 8521795Open reference}1^{1A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage1996 · Biochem Biophys Res Commun · PMID 8521795Open reference}2^{1A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage1996 · Biochem Biophys Res Commun · PMID 8521795Open reference}3

Open Questions

• Which AIF1-associated microglial states are compensatory vs pathogenic across disease stages?

• How should AIF1 be combined with state-specific markers (for example, DAM and interferon-response modules) in trial stratification?

• Can therapies that reduce harmful neuroinflammation preserve beneficial phagocytic functions in AIF1-high populations?

See Also

• Microglia — Resident immune cells of the CNS where AIF1 is predominantly expressed

• Neuroinflammation — Inflammatory processes in neurodegeneration mediated by microglia

• TREM2 — Triggering receptor expressed on myeloid cells 2, another key microglial marker

• Iba1 Protein — Alternative name for AIF1 protein

• Parkinson’s Disease — AD-linked proteinopathies and synucleinopathies

• Alzheimer’s Disease — Major neurodegenerative disease with neuroinflammation component

External Links

• NCBI Gene: AIF1

• UniProt: IBA1 (P35080)

• GeneCards: AIF1

• HGNC: AIF1

Overview

Aif1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Aif1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Experimental Systems and Interpretation Caveats

AIF1 is often treated as a binary marker of “activated” microglia, but modern single-cell and spatial profiling shows that AIF1-high cells span multiple states with different functional consequences.^{1A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage1996 · Biochem Biophys Res Commun · PMID 8521795Open reference}4^{1A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage1996 · Biochem Biophys Res Commun · PMID 8521795Open reference}5 In practice, interpretation should be paired with state-defining markers (for example, lipid-handling, interferon-response, and antigen-presentation modules), regional context, and pathology stage.^{1A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage1996 · Biochem Biophys Res Commun · PMID 8521795Open reference}6^{1A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage1996 · Biochem Biophys Res Commun · PMID 8521795Open reference}7

Preclinical studies commonly combine AIF1 immunoreactivity with readouts of autophagy, synaptic density, and complement deposition to distinguish whether interventions shift microglia toward clearance-supportive versus injury-amplifying programs.^{1A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage1996 · Biochem Biophys Res Commun · PMID 8521795Open reference}8^{1A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage1996 · Biochem Biophys Res Commun · PMID 8521795Open reference}9 This is especially relevant for trials targeting TREM2 therapeutics, NLRP3 inflammasome, or cytokine cascades, where preserving beneficial debris handling is a major translational constraint.^{3Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity2001 · J Neurochem · PMID 11675512Open reference}0^{3Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity2001 · J Neurochem · PMID 11675512Open reference}1